CN105852127A - Hypoglycemic hypolipidemic health-care product and production method - Google Patents
Hypoglycemic hypolipidemic health-care product and production method Download PDFInfo
- Publication number
- CN105852127A CN105852127A CN201610296910.8A CN201610296910A CN105852127A CN 105852127 A CN105852127 A CN 105852127A CN 201610296910 A CN201610296910 A CN 201610296910A CN 105852127 A CN105852127 A CN 105852127A
- Authority
- CN
- China
- Prior art keywords
- parts
- health products
- blood sugar
- health
- reducing blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002218 hypoglycaemic effect Effects 0.000 title abstract description 6
- 230000000055 hyoplipidemic effect Effects 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008280 blood Substances 0.000 claims abstract description 59
- 210000004369 blood Anatomy 0.000 claims abstract description 58
- 150000002632 lipids Chemical class 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 22
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 16
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 238000004806 packaging method and process Methods 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 18
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 17
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 17
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 16
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 16
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 16
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 16
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 16
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 16
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 16
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 16
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 16
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 16
- 241000222336 Ganoderma Species 0.000 claims description 16
- 244000241838 Lycium barbarum Species 0.000 claims description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 15
- 244000197580 Poria cocos Species 0.000 claims description 15
- 235000008599 Poria cocos Nutrition 0.000 claims description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 14
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 14
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 14
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 14
- 240000005373 Panax quinquefolius Species 0.000 claims description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 14
- 244000046146 Pueraria lobata Species 0.000 claims description 14
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 235000020985 whole grains Nutrition 0.000 claims description 12
- 235000013350 formula milk Nutrition 0.000 claims description 6
- 238000005453 pelletization Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract 2
- 230000000087 stabilizing effect Effects 0.000 abstract 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 13
- 230000000694 effects Effects 0.000 description 8
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229930192014 saikosaponin Natural products 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- HSTZMXCBWJGKHG-UHFFFAOYSA-N (E)-piceid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229930185278 anthraglycoside Natural products 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940043316 hawthorn preparation Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 229960003764 polydatin Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- HSTZMXCBWJGKHG-CUYWLFDKSA-N trans-piceid Polymers O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a hypoglycemic hypolipidemic health-care product, made from the following materials according to parts by weight: 30-40 parts of Rhizoma Polygonati, 20-30 parts of Rhizoma Dioscoreae, 10-20 parts of chrysanthemum, 10-30 parts of Fructus Crataegi, 10-20 parts of Radix Panacis Quinquefolii, 20-40 parts of Semen Coicis, 10-30 parts of Radix Puerariae, 20-30 parts of Ganoderma Lucidum seu Japonicum, 6-10 parts of Radix Bupleuri, 10-20 parts of Semen Cassiae, 2-10 parts of Rhizoma Polygoni Cuspidati, 6-12 parts of Fructus Lycii, 10-16 parts of Rhizoma Polygonati Odorati, and 10-18 parts of Poria. A production method of the hypoglycemic hypolipidemic health-care product includes the following steps: (1), selecting materials, and washing for use; (2), preparing: making powder, and mixing; (3), granulating: making a mixture into granules; (4), stabilizing size: drying by spraying, and stabilizing the size with a size stabilizer; (5), packaging: mixing again, charging in a packaging appliance for packaging, and producing the hypoglycemic hypolipidemic health-care product. The health-care product can improve and adjust body immunity, delay senility and tonify qi, and is effective in lowering blood glucose and lipid.
Description
Technical field
The present invention relates to a kind of health products, health products of a kind of reducing blood sugar and blood lipid and preparation method thereof.
Background technology
Along with growth in the living standard, high fat of blood and hyperglycaemia have become as present epidemic disease.The main hazard of hyperlipidemia
It is to cause artery sclerosis, is the important risk factor of fatal disease such as coronary heart disease, cerebral apoplexy, myocardial infarction, also increases the weight of
One of factors of disease such as hypertension, diabetes, fatty liver, cirrhosis, pancreatitis.The infringement of health is by hyperlipidemia
Concealment, gradually, for a long time with general, majority need long-term prescription to treat.If but long-term taking Adjust-blood lipid Western medicine,
The healthy of patient can be made again to suffer damage because of side effects of pharmaceutical drugs.
Summary of the invention
It is an object of the invention to provide health products of a kind of reducing blood sugar and blood lipid and preparation method thereof, to solve above-mentioned background technology
The problem of middle proposition.
For achieving the above object, the present invention provides following technical scheme:
The health products of a kind of reducing blood sugar and blood lipid, include according to the raw material of weight portion: sealwort 30-40 part, Chinese yam 20-30 part,
Chrysanthemum 10-20 part, hawthorn 10-30 part, American Ginseng 10-20 part, heart of a lotus seed benevolence 20-40 part, root of kudzu vine 10-30 part, glossy ganoderma 20-30
Part, radix bupleuri 6-10 part, cassia seed 10-20 part, giant knotweed 2-10 part, matrimony vine 6-12 part, radix polygonati officinalis 10-16 part, Poria cocos
10-18 part.
As the further scheme of the present invention: include according to the raw material of weight portion: sealwort 35 parts, Chinese yam 25 parts, chrysanthemum 15
Part, hawthorn 20 parts, American Ginseng 15 parts, heart of a lotus seed benevolence 30 parts, the root of kudzu vine 20 parts, glossy ganoderma 25 parts, radix bupleuri 8 parts, cassia seed
15 parts, giant knotweed 6 parts, matrimony vine 9 parts, radix polygonati officinalis 13 parts, 14 parts of Poria cocos.
As the present invention further scheme: the preparation method of the health products of described reducing blood sugar and blood lipid, comprise the following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross micro mesh sieve and make powder, by each composition weight hundred
Proportion by subtraction mixes 15-60 minute, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 60-80 °, is dried and is
Moisture is less than 8%, then uses pelletizing machine to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
As the present invention further scheme: described health products can also make capsule, tablet or oral liquid.
As the present invention further scheme: drying temperature in step (2) and be 40-70 DEG C, the time is 6-12 hour.
As the present invention further scheme: the micro mesh sieve in step (2) is 280 mesh.
Giant knotweed its root medicinal, slightly warm in nature, having invigorates blood circulation stimulates the menstrual flow and dampness removing function, is conventionally used to treatment rheumatism, numbness pain, Huang
Subcutaneous ulcer, amenorrhoea, dysmenorrhoea etc..Modern pharmacological research proves, giant knotweed contains anthraquinone analog compound and flavonoids Multiple components, from its root
Stem can extract the polydatin etc. with component for reducing blood fat.About it is demonstrated experimentally that giant knotweed has reduction cholesterol and glycerine three
The effect of ester.
Radix bupleuri medicinal effects is root or the herb of radix bupleuri, bitter, cold nature, enters liver, kidney two warp.It is mainly composed of radix bupleuri
Ketone, phytosterol, aliphatic acid, saikosaponin saikoside, have thin gas, Xie Yu, dissipate effect of fire.Wherein saikosaponin saikoside has fall
Blood fat.
Glossy ganoderma its fructification medicinal, warm in nature, slightly sweet flavor.Glossy ganoderma contains sterol, alkaloid, protein, polysaccharide, class etc..
There is effect of beneficial vital essence, strengthening the bones and muscles.Cure mainly metal fatigue, palpitation and insomnia, hypertension, hypercholesterolemia, the cerebrovascular
Hardening etc..
Hawthorn its dry mature fruit medicinal.Taste acid is sweet, slightly warm in nature.Fructus Crataegi containing crataegolic acid, malic acid, citric acid,
Caffeic acid, lactones, fat, Hyperoside, lipolytic enzyme, tannin, protein, Quercetin, riboflavin, carrotene,
The Multiple components such as carbohydrate and vitamins.Pharmacological research finds, after rabbit serve on hawthorn preparation 3 weeks, serum cholesterol is notable
Decline.The compatibilities such as hawthorn and chrysanthemum, the red sage root, corydalis tuber, honeysuckle flower, safflower, Fructus Hordei Germinatus, can be used for treating hyperlipidemia, high blood
The sensation of oppression and faint pain in the chest that pressure, coronary heart disease are caused.
Cassia seed medicated with the seed of its drying and ripening.Cassia seed sweetness and bitterness is slightly cold, and returns liver, courage, kidney three warp, have heat-clearing,
Improving eyesight, effect of ease constipation.Cassia seed material Han anthraglycosides, produces rheum emodin, Physcion, Rhein, big after decomposition
Yellow phenol and glucose etc., possibly together with retinoid material.It is demonstrated experimentally that cassia seed has lowering blood pressure and blood fat, antibacterial
Deng effect, being used for treating hyperlipidemia has certain curative effect.But it may be noted that have loose bowels and hypotensive is cautious use of cassia seed preparation.
Matrimony vine is tonified the liver and kidney, and delays senility.There is hypoglycemic and hypotensive activity, and have promotion liver cell regeneration and lipotropism fat
The function of liver.
Poria cocos invigorating spleen to remove dampness, has analgesia and hypoglycemic activity.
Compared with prior art, the invention has the beneficial effects as follows: the health products of the present invention can improve and regulate immunity of organisms,
Delaying sanility, tonifying Qi, there is reduction blood sugar and the effect of blood fat.
Detailed description of the invention
Below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described, aobvious
So, described embodiment is only a part of embodiment of the present invention rather than whole embodiments.Based in the present invention
Embodiment, the every other embodiment that those of ordinary skill in the art are obtained under not making creative work premise, all
Belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, the health products of a kind of reducing blood sugar and blood lipid, include according to the raw material of weight portion: sealwort 30 parts,
Chinese yam 20 parts, chrysanthemum 10 parts, hawthorn 10 parts, American Ginseng 10 parts, heart of a lotus seed benevolence 20 parts, the root of kudzu vine 10 parts, glossy ganoderma 20 parts,
Radix bupleuri 6 parts, cassia seed 10 parts, giant knotweed 2 parts, matrimony vine 6 parts, radix polygonati officinalis 10 parts, 10 parts of Poria cocos.
The preparation method of the health products of described reducing blood sugar and blood lipid, comprises the following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross 280 mesh micro mesh sieves and make powder, dry temperature
Being 40 DEG C, the time is 12 hours, mixes 15 minutes by each weight percentages of components, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 60 °, is dried as moisture
Less than 8%, then pelletizing machine is used to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
Embodiment 2
In the embodiment of the present invention, the health products of a kind of reducing blood sugar and blood lipid, include according to the raw material of weight portion: sealwort 35 parts,
Chinese yam 25 parts, chrysanthemum 15 parts, hawthorn 20 parts, American Ginseng 15 parts, heart of a lotus seed benevolence 30 parts, the root of kudzu vine 20 parts, glossy ganoderma 25 parts,
Radix bupleuri 8 parts, cassia seed 15 parts, giant knotweed 6 parts, matrimony vine 9 parts, radix polygonati officinalis 13 parts, 14 parts of Poria cocos.
The preparation method of the health products of described reducing blood sugar and blood lipid, comprises the following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross 280 mesh micro mesh sieves and make powder, dry temperature
Being 50 DEG C, the time is 10 hours, mixes 30 minutes by each weight percentages of components, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 70 °, is dried as moisture little
In 8%, then pelletizing machine is used to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
Embodiment 3
In the embodiment of the present invention, the health products of a kind of reducing blood sugar and blood lipid, include according to the raw material of weight portion: sealwort 40 parts,
Chinese yam 30 parts, chrysanthemum 20 parts, hawthorn 30 parts, American Ginseng 20 parts, heart of a lotus seed benevolence 40 parts, the root of kudzu vine 30 parts, glossy ganoderma 30 parts,
Radix bupleuri 10 parts, cassia seed 20 parts, giant knotweed 10 parts, matrimony vine 12 parts, radix polygonati officinalis 16 parts, 18 parts of Poria cocos.
The preparation method of the health products of described reducing blood sugar and blood lipid, comprises the following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross 280 mesh micro mesh sieves and make powder, dry temperature
Being 70 DEG C, the time is 6 hours, mixes 60 minutes by each weight percentages of components, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 80 °, is dried as moisture
Less than 8%, then pelletizing machine is used to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
Embodiment 4
In the embodiment of the present invention, the health products of a kind of reducing blood sugar and blood lipid, include according to the raw material of weight portion: sealwort 30 parts,
Chinese yam 30 parts, chrysanthemum 18 parts, hawthorn 15 parts, American Ginseng 20 parts, heart of a lotus seed benevolence 35 parts, the root of kudzu vine 20 parts, glossy ganoderma 30 parts,
Radix bupleuri 6 parts, cassia seed 10 parts, giant knotweed 5 parts, matrimony vine 10 parts, radix polygonati officinalis 15 parts, 18 parts of Poria cocos.
The preparation method of the health products of described reducing blood sugar and blood lipid, comprises the following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross 280 mesh micro mesh sieves and make powder, dry temperature
Being 60 DEG C, the time is 10 hours, mixes 45 minutes by each weight percentages of components, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 80 °, is dried as moisture
Less than 8%, then pelletizing machine is used to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
Described health products can also make capsule, tablet or oral liquid.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, and do not carrying on the back
In the case of the spirit or essential attributes of the present invention, it is possible to realize the present invention in other specific forms.Therefore, no matter from
From the point of view of which point, all should regard embodiment as exemplary, and be nonrestrictive, the scope of the present invention is by appended power
Profit requires rather than described above limits, it is intended that all by fall in the implication of equivalency and scope of claim
Change is included in the present invention.
Although moreover, it will be appreciated that this specification is been described by according to embodiment, but the most each embodiment only comprises
One independent technical scheme, this narrating mode of specification is only the most for clarity sake, and those skilled in the art should be by
Specification is as an entirety, and the technical scheme in each embodiment can also be through appropriately combined, and forming those skilled in the art can
With other embodiments understood.
Claims (6)
1. the health products of a reducing blood sugar and blood lipid, it is characterised in that include according to the raw material of weight portion: sealwort 30-40 part,
Chinese yam 20-30 part, chrysanthemum 10-20 part, hawthorn 10-30 part, American Ginseng 10-20 part, heart of a lotus seed benevolence 20-40 part, root of kudzu vine 10-30
Part, glossy ganoderma 20-30 part, radix bupleuri 6-10 part, cassia seed 10-20 part, giant knotweed 2-10 part, matrimony vine 6-12 part, radix polygonati officinalis
10-16 part, Poria cocos 10-18 part.
The health products of reducing blood sugar and blood lipid the most according to claim 1, it is characterised in that according to the raw material bag of weight portion
Include: sealwort 35 parts, Chinese yam 25 parts, chrysanthemum 15 parts, hawthorn 20 parts, American Ginseng 15 parts, heart of a lotus seed benevolence 30 parts, the root of kudzu vine 20
Part, glossy ganoderma 25 parts, radix bupleuri 8 parts, cassia seed 15 parts, giant knotweed 6 parts, matrimony vine 9 parts, radix polygonati officinalis 13 parts, 14 parts of Poria cocos.
3. the preparation method of the health products of the reducing blood sugar and blood lipid as described in claim 1-2 is arbitrary, it is characterised in that bag
Include following steps:
(1) select materials: by the selected sealwort of above-mentioned formula, Chinese yam, chrysanthemum, hawthorn, American Ginseng, heart of a lotus seed benevolence, the root of kudzu vine, glossy ganoderma,
Radix bupleuri, cassia seed, giant knotweed, matrimony vine, radix polygonati officinalis and Poria cocos, standby after being cleaned respectively;
(2) produce: above-mentioned raw materials uses low baking temperature dry, pulverize, cross micro mesh sieve and make powder, by each composition weight hundred
Proportion by subtraction mixes 15-60 minute, makes mixed material;
(3) pelletize: described mixed material is placed on granulator and pelletizes, mixture is fabricated to graininess shape;
(4) whole grain: particle step (3) made is spray-dried under conditions of temperature is 60-80 °, is dried and is
Moisture is less than 8%, then uses pelletizing machine to carry out whole grain;
(5) packaging: remixed by the particle that step (4) makes, wraps remixing particles filled the arriving produced
Pack in assembling device, finally produce the health products of reducing blood sugar and blood lipid.
The preparation method of the health products of reducing blood sugar and blood lipid the most according to claim 3, it is characterised in that described health care
Product can also make capsule, tablet or oral liquid.
The preparation method of the health products of reducing blood sugar and blood lipid the most according to claim 3, it is characterised in that step (2)
Middle drying temperature is 40-70 DEG C, and the time is 6-12 hour.
The preparation method of the health products of reducing blood sugar and blood lipid the most according to claim 3, it is characterised in that step (2)
In micro mesh sieve be 280 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296910.8A CN105852127A (en) | 2016-05-05 | 2016-05-05 | Hypoglycemic hypolipidemic health-care product and production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610296910.8A CN105852127A (en) | 2016-05-05 | 2016-05-05 | Hypoglycemic hypolipidemic health-care product and production method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105852127A true CN105852127A (en) | 2016-08-17 |
Family
ID=56630482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610296910.8A Pending CN105852127A (en) | 2016-05-05 | 2016-05-05 | Hypoglycemic hypolipidemic health-care product and production method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105852127A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106360731A (en) * | 2016-09-28 | 2017-02-01 | 天津拓华生物科技有限责任公司 | Insect oil health-care product and preparation method thereof |
CN106962921A (en) * | 2017-03-07 | 2017-07-21 | 王绍坤 | A kind of health diet addition powder and preparation method thereof |
CN107136357A (en) * | 2017-06-01 | 2017-09-08 | 吴天明 | A kind of CHAGA health beverages and preparation method |
CN107927769A (en) * | 2017-12-12 | 2018-04-20 | 四川旭阳药业有限责任公司 | A kind of compound health products and preparation method thereof |
CN108208655A (en) * | 2018-01-24 | 2018-06-29 | 浙江中医药大学 | A kind of pure natural functional food with lower hyperlipidemia, hypertension, hyperglycemia and preparation method thereof |
CN108294232A (en) * | 2017-12-19 | 2018-07-20 | 丽睿客信息科技(北京)有限公司 | Nutritional staple food with function of blood sugar reduction |
CN109247536A (en) * | 2018-09-25 | 2019-01-22 | 武汉万密斋养生堂科技发展股份有限公司 | A kind of food granule of strengthen immunity and preparation method thereof |
CN109602850A (en) * | 2019-01-09 | 2019-04-12 | 齐广金 | A kind of pueraria lobata radix polygonati officinalis particle and its process flow |
CN113509522A (en) * | 2020-04-11 | 2021-10-19 | 北京永康古草中医科技有限公司 | A Chinese medicinal health product for delaying aging, and its preparation method |
CN114224977A (en) * | 2022-01-12 | 2022-03-25 | 李望 | Traditional Chinese medicine for regulating hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59106276A (en) * | 1982-12-09 | 1984-06-19 | Osaka Chem Lab | Health food |
CN1961744A (en) * | 2006-12-08 | 2007-05-16 | 富天桂 | A health food |
CN101890124A (en) * | 2009-05-23 | 2010-11-24 | 潘健 | Chinese medicinal health care product with blood fat reduction effect |
CN101966326A (en) * | 2009-07-28 | 2011-02-09 | 潘健 | Health-care product for improving human immunity |
CN102630934A (en) * | 2011-12-21 | 2012-08-15 | 王广仪 | Micro-element oral liquid capable of regulating blood sugar and blood lipid |
CN105381420A (en) * | 2015-12-30 | 2016-03-09 | 孙喜范 | Traditional Chinese medicine for treating fatty liver |
-
2016
- 2016-05-05 CN CN201610296910.8A patent/CN105852127A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59106276A (en) * | 1982-12-09 | 1984-06-19 | Osaka Chem Lab | Health food |
CN1961744A (en) * | 2006-12-08 | 2007-05-16 | 富天桂 | A health food |
CN101890124A (en) * | 2009-05-23 | 2010-11-24 | 潘健 | Chinese medicinal health care product with blood fat reduction effect |
CN101966326A (en) * | 2009-07-28 | 2011-02-09 | 潘健 | Health-care product for improving human immunity |
CN102630934A (en) * | 2011-12-21 | 2012-08-15 | 王广仪 | Micro-element oral liquid capable of regulating blood sugar and blood lipid |
CN105381420A (en) * | 2015-12-30 | 2016-03-09 | 孙喜范 | Traditional Chinese medicine for treating fatty liver |
Non-Patent Citations (3)
Title |
---|
凌关庭: "《保健食品原料手册(第二版)》", 31 May 2007, 化学工业出版社 * |
南京中医药大学: "《中药大辞典 第2版》", 31 March 2006, 上海科学技术出版社 * |
宋梅等: "《药学综合实训》", 31 August 2013, 中国医药科技出版社 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106360731A (en) * | 2016-09-28 | 2017-02-01 | 天津拓华生物科技有限责任公司 | Insect oil health-care product and preparation method thereof |
CN106962921A (en) * | 2017-03-07 | 2017-07-21 | 王绍坤 | A kind of health diet addition powder and preparation method thereof |
CN107136357A (en) * | 2017-06-01 | 2017-09-08 | 吴天明 | A kind of CHAGA health beverages and preparation method |
CN107927769A (en) * | 2017-12-12 | 2018-04-20 | 四川旭阳药业有限责任公司 | A kind of compound health products and preparation method thereof |
CN108294232A (en) * | 2017-12-19 | 2018-07-20 | 丽睿客信息科技(北京)有限公司 | Nutritional staple food with function of blood sugar reduction |
CN108208655A (en) * | 2018-01-24 | 2018-06-29 | 浙江中医药大学 | A kind of pure natural functional food with lower hyperlipidemia, hypertension, hyperglycemia and preparation method thereof |
CN109247536A (en) * | 2018-09-25 | 2019-01-22 | 武汉万密斋养生堂科技发展股份有限公司 | A kind of food granule of strengthen immunity and preparation method thereof |
CN109602850A (en) * | 2019-01-09 | 2019-04-12 | 齐广金 | A kind of pueraria lobata radix polygonati officinalis particle and its process flow |
CN113509522A (en) * | 2020-04-11 | 2021-10-19 | 北京永康古草中医科技有限公司 | A Chinese medicinal health product for delaying aging, and its preparation method |
CN114224977A (en) * | 2022-01-12 | 2022-03-25 | 李望 | Traditional Chinese medicine for regulating hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105852127A (en) | Hypoglycemic hypolipidemic health-care product and production method | |
CN1047946C (en) | Preparation for treating senile diseases | |
CN1227728A (en) | Flavouring nutritive health food capable of refreshing oneself, relieving summer heat and curing disease | |
CN103520577A (en) | Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation | |
CN104055871A (en) | Traditional Chinese medicinal composition for improving sleeping quality and application of traditional Chinese medicinal composition | |
CN103623341A (en) | Drug for treating hypertension and cardiovascular and cerebrovascular diseases caused by hypertension | |
CN103099833A (en) | Soft capsule helpful for relieving sports fatigue and delaying aging and preparation method thereof | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN105918946A (en) | Red date and Chinese wolfberry fruit liver tonifying composition, granules and preparation method thereof | |
CN103960429A (en) | Health food with effect of healthily reducing weight of user | |
CN1029081C (en) | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" | |
CN102266052A (en) | Health care food with function of improving sleeping | |
CN102302609A (en) | Compound traditional Chinese drug preparation for improving subhealth | |
CN105994867A (en) | Chocolate with effect of improving immunity and preparation method thereof | |
CN102823700A (en) | Preparation method of compound poria cocos and black garlic filled chocolate | |
CN109999058A (en) | A kind of molten method of glue class Chinese medicine and product, and the solid beverage as made from the product and preparation method thereof | |
CN103039891B (en) | Lotus root starch capable of nourishing yin and clearing heat and preparation method thereof | |
CN102698099B (en) | Pill for treating diabetes mellitus | |
CN104225425A (en) | Chinese herbal preparation for enhancing immunity, improving sleep and preventing cardio-cerebrovascular disease, and preparation method thereof | |
CN106173128A (en) | A kind of chocolate with anti-fatigue effect and preparation method thereof | |
CN113018404A (en) | Blood stasis constitution health-care solid beverage and preparation method thereof | |
CN104938918A (en) | Nutritional wheat flour capable of regulating blood lipids | |
CN105726921A (en) | Traditional Chinese medicine composition and preparation for treating deficiency of both qi and blood | |
CN112914009A (en) | Health-care solid beverage for yang-deficiency constitution and preparation method thereof | |
CN112914097A (en) | Health-care solid beverage for damp-heat constitution and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
RJ01 | Rejection of invention patent application after publication |